WPCS International Incorporated (NASDAQ:WPCS) announced after the close of trading on Thursday that BTX Trader LLC, its 100%-owned subsidiary, has now released a beta-version of its Windows-based trading-platform and is available to the public at www.btxtrader.com. BTX Trader is the first trading-platform to enable Bitcoin traders to access the market data and execute their orders on the 5 most-popular Bitcoin exchanges.BIOLASE Inc (NASDAQ:BIOL) stock in last trading day opened at $2.16, traded the day range of $2.16 – $2.64, and closed at $2.60. The stock showed a positive performance of 20.93% in previous trading session.
CytRx Corporation (NASDAQ:CYTR)’s oncology pipeline announced three programs in clinical development for cancer indications: INNO-206, tamibarotene and bafetinib. INNO-206 is the Company’s tumor-targeted doxorubicin conjugate. CytRx Corporation (NASDAQ:CYTR) traded 41.98million shares and the average volume of the stock was recorded as 4.36million shares. The 52 week range of the stock is $4.53- $5.40. The stock was advanced 13.85% by closing at $5.26.
Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP) is engaged in the research and development of pharmaceutical solutions for the use of orally ingestible capsules or pills for delivery of polypeptides.Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP) stock on December 27, 2013, recorded a rise of 9.99% and was in a range of $11.80 – $13.54 before closing at $12.99. Company’s 52-week low price is $3.72 and 52 week high price is $16.38.
The company announced that Mark J. Ahn, Ph.D., President and Chief Executive Officer, presented a corporate update at the Oppenheimer 24th Annual Healthcare Conference. The presentation took place on Tuesday, December 10, 2013 at 10:55 a.m. ET at the Crowne Plaza Hotel in New York, NY.
Research firm Oppenheimer initiated coverage on the stocks of Galena Biopharma Inc (NASDAQ:GALE) to an Outperform rating on Nov. 26. Galena Biopharma Inc (NASDAQ:GALE) shares rise 5.41% in last trading session and was closed at $4.29, while trading in range of $4.09-$4.35. . Its return on equity ratio is recorded as-163.70 % and its return on assets is -61.20%.